UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030811
Receipt number R000035016
Scientific Title Long term follow-up protocol of phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.(WJOG0105LFS)
Date of disclosure of the study information 2018/01/15
Last modified on 2021/10/08 16:25:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long term follow-up protocol of phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.(WJOG0105LFS)

Acronym

Follow up study of WJTOG0105

Scientific Title

Long term follow-up protocol of phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.(WJOG0105LFS)

Scientific Title:Acronym

Follow up study of WJTOG0105

Region

Japan


Condition

Condition

Non-small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is that we investigate long term follow-up results of third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Prgression-free survival, Pattern of relapse, Post treatment after progression, Late toxicity.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

All cases of registerd with WJTOG0105.

Key exclusion criteria

None

Target sample size

440


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Tsuboi

Organization

National Cancer Center Hospital East

Division name

Thoracic Surgery

Zip code

277-8577

Address

6-5-1 Kashiwanoha, Kashiwa City, Chiba Prefecture, Japan

TEL

04-7133-1111

Email

mtsuboi@east.ncc.go.jp


Public contact

Name of contact person

1st name Shinichiro
Middle name
Last name Nakamura

Organization

West Japan Oncology Group

Division name

WJOG datacenter

Zip code

556-0016

Address

Namba Plaza Bldg. 304-1-5-7, Motomachi Naniwa-ku, Osaka 556-0016 JAPAN

TEL

06-6633-7400

Homepage URL


Email

datacenter@wjog.jp


Sponsor or person

Institute

West Japan Oncology Group

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Address

3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677

Tel

03-3823-2101

Email

yzenke@cick.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

331

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 13 Day

Date of IRB

2018 Year 01 Month 30 Day

Anticipated trial start date

2018 Year 03 Month 01 Day

Last follow-up date

2019 Year 12 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective analysis of long-term follow-up survival with WJTOG0105.


Management information

Registered date

2018 Year 01 Month 15 Day

Last modified on

2021 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035016


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name